Table 2.

Prognostic factors in advanced gastric cancer

	Chau et al. [25]	Takahari et al. [26]	Lee et al. [27]	Kim et al. [28]	Koo et al. [29]	Fanotto et al. [31]	Fuchs et al. [41]
Host status
ECOG PS	●	●	●	●	●	●	●
Tumor status
No gastrectomy		●	●		●		●
Peritoneal metastasis	●		●	●	●		●
Bone metastasis			●	●	●
Liver metastasis	●
Lung metastasis					●
Number of metastatic sites		●		●
First-line TTP/PFS						●	●
Laboratory test values
Increased ALP	●	●	●		●		●
Increased AST		●					●
Decreased albumin			●		●		●
Elevated total bilirubin				●	●
Increased LDH						●	●
NLR						●

ECOG PS: Eastern Cooperative Oncology Group performance status; TTP: time to progression; PFS: progression-free survival; ALP: alkaline phosphatase; AST: aspartate transaminase; LDH: lactate dehydrogenase; NLR: neutrophil-to-lymphocyte ratio. References [30] and [40] are reports on second-line treatment